{"id":"W6902432487","doi":"10.7016/j.ahj.2004.09.047","title":"Rationale - Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease","year":2005,"lang":"en","type":"article","venue":"University of Groningen research database (University of Groningen / Centre for Information Technology)","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Darbepoetin alfa; Kidney disease; Anemia; Population; Clinical endpoint; Randomized controlled trial; Disease; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02511253,0.002310017,0.003140157,0.0006650916,0.0009855997,0.002518875,0.001598181,0.006257448,0.01928608],"category_scores_gemma":[0.03134694,0.0009078722,0.003503189,0.0008257165,0.002044728,0.002231855,0.0009636626,0.005080748,0.004556293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001236249,"about_ca_system_score_gemma":0.005726032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008998518,"about_ca_topic_score_gemma":0.001927168,"domain_scores_codex":[0.9811569,0.01444804,0.001389625,0.001319196,0.001174169,0.0005120031],"domain_scores_gemma":[0.9891052,0.004537077,0.002052425,0.0008945586,0.001689371,0.001721269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.781443,0.004027532,0.004273358,0.03348099,0.007917556,0.0002186292,0.0002408341,0.001410839,0.002632477,0.01419043,0.05315156,0.09701278],"study_design_scores_gemma":[0.9123571,0.02078044,0.002975625,0.004201824,0.004093986,0.00009833783,0.00005653748,0.001147766,0.000644862,0.006189825,0.04738103,0.00007270004],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.07004482,0.05838528,0.01771255,0.07467364,0.02867031,0.6678092,0.0316285,0.00113708,0.04993857],"genre_scores_gemma":[0.1850489,0.01337106,0.06607567,0.05119833,0.007260616,0.6556947,0.007572073,0.0001663101,0.01361235],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.02511253,"threshold_uncertainty_score":0.1328093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01470498810246087,"score_gpt":0.2312624110098274,"score_spread":0.2165574229073665,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}